Protini peptide review: the cream, refill and result percentages

The title identifies a refillable gel-cream

The heading names Protini Polypeptide Firming Refillable Moisturizer, and the adjacent description calls it a refillable peptide-packed gel-cream. Those are the current product’s own identity statements. They support treating this record as a cream-format moisturizer with advertised refillability.

That does not establish how a refill was supplied to any buyer, authenticate a package or document that the formula changed when refill wording appeared. The record concerns the named product page rather than an observed handling experience. The full title matters because an abbreviated peptide reference would omit the physical format being discussed.

The cream-format description and advertised refillability can be documented without describing a refill process. They also should not imply that a refill and an earlier container were analytically compared. That would require identified versions and relevant records, none of which were inspected here. The current page is the evidence unit: its product title, texture wording and declaration belong together, while a historical formula or packaging transition remains outside what this reading establishes.

The copper name sits within a complete list

The captured declaration contains Copper Palmitoyl Heptapeptide-14, together with other peptides and numerous formulation ingredients. The literal list gives the declared copper ingredient its place within a finished moisturizer. It does not supply the quantity of that entry or prove that it independently causes the product’s claimed firming effects.

This is a name-based disclosure, not a copper assay. No individual peptide split, purity certificate or quantitative refill comparison was examined. The grade-and-purity guide separates those absent analytical records from a manufacturer’s ingredient declaration, without treating the absence itself as evidence of a defective product.

Nine signal peptides remains a count

Drunk Elephant highlights nine signal peptides in its key-ingredient explanation. That wording describes the manufacturer’s peptide grouping. The highlight panel does not state nine percent copper or disclose equal shares among the peptides. The count cannot be divided into a recipe or used as an independently checked strength score.

Other aspects of the base remain part of the cream’s identity, even though the peptide count is easy to remember. A separate count-focused reading appears in the COSRX review. The two records can be explored together without assuming that more named peptides establish more benefit.

The free-from percentage concerns excluded categories

The page says the formula is 100% free of specified categories, including essential oils, silicones, fragrance or dyes, and solvent alcohols. This is an attributed manufacturer exclusion statement. The number does not describe copper purity, total peptide loading or a tested absence of every possible unwanted constituent.

Its scope should remain the categories actually named. It also does not establish a reader’s tolerance, and this review performed no ingredient assay to confirm the statement. The free-from wording, refill identity and copper declaration answer separate product questions; combining them cannot fill the missing individual constituent quantities.

The result panel needs its endpoint labels

The source reports that 96% showed improvement in tone, radiance and luminosity, 93% showed improvement in texture, and 90% showed improvement in hydration. The star note identifies a clinical study with 31 people after eight weeks. These are the manufacturer’s particular result statements, not a claim that wrinkles decreased by 96% or that copper occupies 90% of the cream.

The complete report, measurement procedures, comparison conditions and individual distributions were not reviewed. The percentages remain attributed summaries of the listed endpoints. The study-endpoint guide explains why an outcome label cannot be discarded when a favorable number is quoted.

A clinical label does not identify every assessment method

The product page describes its results as clinical, but the examined panel and footnote do not give all the methods needed to classify each assessment. The presence of a study label does not make every improvement phrase an instrument-measured value or show a copper-only comparison.

FDA’s assessment explanation distinguishes reports from patients, observers and clinicians, as well as performance measures. It is useful vocabulary here, not a qualification of the Protini study. FDA also says formal qualification is not required for every trial endpoint; this review does not invent such a requirement or dismiss the summary on that basis.

The current identity is stronger than an assumed history

The page establishes how Drunk Elephant currently presents this refillable moisturizer, which copper name it declares and which result summaries it publishes. It does not establish a formula transition, a refill assay or comparative clinical superiority. Those limits remain beside the current record.

For other document boundaries, continue to the Naturium review or the original source comparison. These are reading paths, not evidence that another brand’s package history resolves Protini’s. The cream, its count and its qualified result panel can be described accurately without supplying the missing numerical formula.